PA
BDSI

Perceptive Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Perceptive Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-605,407
Closed -$7.28M – 203
2014
Q4 		$7.28M Buy
605,407
+299,407
+98% +$4.55M 0.61% 40
2014
Q3 		$5.23M Sell
306,000
-394,000
-56% -$5.72M 0.53% 46
2014
Q2 		$8.45M Buy
700,000
+510,000
+268% +$4.84M 0.83% 38
2014
Q1 		$1.6M Buy
+190,000
New +$1.53M 0.17% 77
2013
Q3 		– Sell
-477,600
Closed -$1.94M – 136
2013
Q2 		$1.94M Buy
+477,600
New +$2.24M 0.2% 47

Other funds holding BDSI

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors's BDSI Position: Q1 2015 in Review

Perceptive Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2015, closing a stake of 605,407 shares — an estimated $7.28M sold.

Perceptive Advisors first reported a position in BDSI in Q2 2013 and held it in 5 quarters. The position peaked at $8.45M in Q2 2014. 147 funds tracked by Wall St. Rank hold BDSI as of Q1 2015.

  • Perceptive Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2015 after selling out during the quarter.
  • Perceptive Advisors sold 605,407 BioDelivery Sciences International, Inc. shares in Q1 2015, an estimated $7.28M.
  • Perceptive Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 5 quarters.
  • Perceptive Advisors's BioDelivery Sciences International, Inc. position peaked at $8.45M in Q2 2014.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2015.

Based on Perceptive Advisors's 13F filing for Q1 2015, filed 15 May 2015.